SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure as investors aggressively rotate capital out of software and into memory-heavy AI infrastructure plays. Community sentiment is deeply divided between those viewing the steep decline as a generational buying opportunity and those fearing a prolonged structural breakdown driven by unsustainable capital expenditure.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending following a massive surge in the semiconductor sector driven by strong earnings and positive forward guidance from Micron. The community is actively debating whether the rally reflects a structural multi-year supercycle in memory demand or an unsustainable bubble, with intense speculation from traders regarding the potential for stock splits and the sustainability of record-high margins.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors interpret a recent regulatory filingwhich updates executive change-of-control agreementsas strategic preparation for a potential acquisition. This upward momentum is being further fueled by intense community discussion regarding a looming clinical catalyst and significant short-covering pressure in a stock with high borrow fees.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending due to intense speculation ahead of its upcoming earnings report, with community sentiment deeply polarized between investors viewing the current valuation as a generational buying opportunity and those fearing a long-term decline. Active discussions focus on a leadership transition involving a new CFO, rumors of potential share buybacks, and the impact of the FIFA World Cup on brand visibility versus persistent skepticism over the company's innovation pipeline and margin recovery.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing heightened social sentiment driven by the combination of an aggressive share buyback program and significant short interest, creating a setup that many retail traders are tracking as a potential squeeze candidate. Community members are actively debating the company's turnaround progress and using technical indicators to identify key levels that could force short sellers to cover their positions.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing heightened volatility as investors debate the impact of prediction markets on its core sportsbook business, with community sentiment sharply divided between those seeing a long-term value opportunity and others concerned about intensifying competition from entities like Meta. This trend is fueled by massive engagement around the World Cup, prompting intense debate over whether these new event-driven products will cannibalize existing revenue or successfully expand the company's total addressable market.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as traders analyze the company's record-breaking earnings and surging AI memory demand, which have sparked intense debate over whether the stock is undergoing a long-term structural re-rating or a classic cycle peak. The community remains deeply polarized, with bulls pointing to massive supply contracts and analyst upgrades as proof of a new growth trajectory, while skeptical bears emphasize the risks of commoditization, margin durability, and potential overvaluation.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is generating significant retail buzz driven by unconfirmed M&A speculation and high-volume option activity, despite ongoing community frustration regarding stock price stagnation and management performance. Investors remain divided between holding for a potential long-term biotech sector rotation and calling for an immediate buyout to resolve perceived institutional manipulation.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing a sharp momentum unwind as high-multiple AI software names face a broader market repricing, with community sentiment deeply divided between investors viewing the pullback as a generational buying opportunity and critics pointing to stretched valuations and institutional selling pressure. Traders are closely watching the $100 psychological support level while debating whether recent price action represents a healthy consolidation of long-term AI infrastructure growth or a breakdown in technical structure.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is facing intense community frustration as shares underperform the broader pharma sector, with investors calling for a leadership change due to perceived value destruction and recent clinical trial setbacks. While some remain attracted to the company's dividend yield and speculative interest in its GLP-1 and oncology pipeline, sentiment is dominated by disappointment over stagnant growth and unfavorable comparisons to peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A few small caps I’m watching here — dip looks like it’s setting up, not breaking down. 
Forward PE &lt; 10 while growth is still accelerating = where asymmetry lives. 
OCF +50% QoQ 
Revenue +50% QoQ 
2026 growth ~50% 
Gross profit +200% YoY / +75% QoQ 
Margins already &gt;5% 
These are the types of numbers institutions chase after the move, not before it. 
$MU (Micron Technology) 
$SNDK (SanDisk) 
$CDLR (Codere Online) 
$TOYO (TOYO Co) 
Still early. Don’t overthink it. 
 
Follow me    👉@ChipDistribution7 for real-time updates and everything. Let’s make moves!

Darzens

StockTwits Web

Cadeler AS - ADR

TOYO Co., Ltd

A few small caps I’m watching here — dip looks like it’s setting up, not breaking down. 
Forward PE < 10 while growth is still accelerating = where asymmetry lives. 
OCF +50% QoQ 
Revenue +50% QoQ 
2026 growth ~50% 
Gross profit +200% YoY / +75% QoQ 
Margins already >5% 
These are the types of numbers institutions chase after the move, not before it. 


 (TOYO Co) 
Still early. Don’t overthink it. 
 
Follow me    👉

 for real-time updates and everything. Let’s make moves!